AMY GIBBENS: Open Payments
NPI 1679001754 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 64 payments from 32 companies in 2025. Trend: 2023 $1,371 · 2024 $1,498 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $167 |
| ABBVIE INC. | 7 | $142 |
| Dexcom, Inc. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $96 |
| Ardelyx, Inc. | 3 | $87 |
| Radius Health, Inc. | 3 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Lundbeck LLC | 2 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
Products named: REXULTI, Dexcom G6 Transmitter, Ozempic, CAPLYTA, IBSRELA, Tymlos, FANAPT, Wegovy.
Industry payments across MO — which companies pay providers there.
